Clinical trial
Introduction of the Maastro Applicator for Endoluminal Boosting in Rectal Cancer: a Pilot Study
NCT06087718 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Introduction of the Maastro Applicator for Endoluminal Boosting in Rectal Cancer: a Pilot Study
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 27, 2024
- Completion date
- April 30, 2031
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brachytherapy, complete response, feasibility, quality of life, radiation proctitis, radiation toxicity, rectal cancer, toxicity